Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden | Open Heart

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

Authors

About

Topic collection
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Heart failure and cardiomyopathies

Original research

Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden

Online download statistics by month:

Online download statistics by month: October 2021 to March 2024

	Abstract	Full	Pdf
Oct 2021	327	323	94
Nov 2021	127	120	51
Dec 2021	115	109	54
Jan 2022	136	139	91
Feb 2022	156	161	68
Mar 2022	267	271	103
Apr 2022	284	286	84
May 2022	241	240	73
Jun 2022	193	193	58
Jul 2022	220	216	50
Aug 2022	211	215	65
Sep 2022	241	239	69
Oct 2022	266	271	46
Nov 2022	198	197	37
Dec 2022	153	152	29
Jan 2023	206	207	44
Feb 2023	207	210	38
Mar 2023	201	194	49
Apr 2023	179	180	59
May 2023	163	156	41
Jun 2023	208	207	21
Jul 2023	275	276	27
Aug 2023	274	275	41
Sep 2023	219	218	46
Oct 2023	264	261	31
Nov 2023	255	236	42
Dec 2023	216	169	46
Jan 2024	145	127	31
Feb 2024	161	141	38
Mar 2024	210	208	116
Total	6318	6197	1642